content_copy Investor Relations - Vitro Biopharma

Investor Relations

Vitro Biopharma is a clinical-stage biotechnology company focused on developing Wharton's jelly-derived cell therapies and targeting new treatments for millions of patients with rare and broad indications. Our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market. The cells when stored properly have an indefinite shelf life and are young, providing the most potent, vibrant stem cells in contrast to autologous. The current pipeline can be used to treat a multitude of diseases and is advancing multiple clinical trials across its product portfolio.  

Become an Investor

Become a Vitro Biopharma investor today. Call (1)866-848-7627 or email or leave us a message here.